Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of MPP7 protein | affects expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MPP7 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MPP7 mRNA | decreases expression | 19150397
|
D003010 |
Clorgyline |
Clorgyline results in increased expression of MPP7 mRNA | increases expression | 19691856
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of MPP7 mRNA | decreases expression | 16510598
|
C051890 |
irinotecan |
irinotecan analog results in increased expression of MPP7 mRNA | increases expression | 18927307
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of MPP7 mRNA | increases expression | 18301758
|
D012402 |
Rotenone |
Rotenone results in decreased expression of MPP7 mRNA | decreases expression | 19013527
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MPP7 mRNA | decreases expression | 19933214
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.13 | 14514962 11752688 15322242 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.55 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.55 | 17638652 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.76 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.87 | 16835633 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
9.33 | 17963324 15504547 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.33 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.33 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.83 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
1.83 | 18608205 15136595 16557594 16110121 16595493 19217205 18357371 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.99 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.74 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.74 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.23 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.23 | 17088986 16332177 16799960 17045692 18930000 17971768 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.10 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.81 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.81 | 17066447 16280240 16757204 18986760 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.86 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.18 | 16354765 8697196 15668235 15340226 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
4.07 | 15001691 17287894 16510598 17018589 17725105 17172411 16340194 17016597 18772588 17169374 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
4.07 | 17725105 17287894 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.77 | 17255274 20501625 16331619 17401013 14970324 16282729 15289873 17454858 18949393 16303861 18288408 18509181 17594712 18802399 18448328 18383874 17016601 15148649 16391804 16524972 17094418 17695437 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.77 | 16303861 18259882 15273666 17159606 17454858 16391804 18509181 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.08 | 16733453 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.58 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.23 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.23 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 16714409 15322242 18230668 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.50 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.50 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.50 | 16337965 16481741 15173087 16785472 17638652 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.97 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.71 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.94 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.52 | 15162350 18337622 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.77 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.77 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.65 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.14 | 16221962 19772884 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.14 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 15340226 18606429 16354765 16959395 8697196 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.76 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
3.48 | 16985049 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.98 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.98 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
14.98 | 17045692 15113037 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.98 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.98 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.21 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.21 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
5.00 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
5.00 | 20869020 20464547 20135361 17053015 6695378 18520028 20064080 18569708 18816296 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
5.00 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
5.00 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.08 | 15086387 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
9.06 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
9.06 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.29 | 17159606 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
3.24 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.76 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.76 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.76 | 17405874 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
4.04 | 18619942 17356569 15790535 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
3.57 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
5.01 | 8761367 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.57 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.72 | 16500647 16929163 15113037 19003803 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
3.04 | 16140633 11445065 18619942 15451049 18191903 11535288 19232380 19114014 16412576 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
4.27 | 15795934 15574749 15927086 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11222880 11118676 11399792 11896295 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.66 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Clorgyline |
2.66 | 19691856 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.66 | 18626508 19082440 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.19 | 18722050 16160472 18286688 15538739 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.76 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.76 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.53 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
3.53 | 17522103 15786421 18396642 16951190 18567086 19015929 16424979 19084572 17498489 17172411 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.53 | 15723263 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.18 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.24 | 17053015 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.07 | 16803524 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |